High unmet medical need for therapies that can reduce the substantial treatment burden affecting millions of patients globallyCombined in-licensing and ...

The Company continues to anticipate that the totality of its early-stage research programs will comprise less than 20% of overall expenditure.

Undoubtedly, after years of neglect, bronchiectasis has become a focus of respiratory research, largely thanks to the establishment of various bronchiectasis registries. Baseline data from registries ...

Harbour BioMed (HKEX: 02142, the "Company"), a global biopharmaceutical company committed to the discovery, development and commercialization of novel antibody therapeutics focusing on immune-oncology ...

Physicians recommend that patients with chronic obstructive pulmonary disease (COPD) quit smoking and use steroids, ...

For patients with COPD, budesonide-glycopyrrolate-formoterol does not improve clinical outcomes compared with fluticasone-umeclidinium-vilanterol.

Boobalan Pachaiyappan, an analyst from Roth MKM, has initiated a new Buy rating on Verona Pharma (VRNA).Stay Ahead of the Market:Discover ...

Sanofi’s Dupixent and new drugs drive growth, despite near-term pressures. See why SFY stock’s product pipeline makes it a ...

Yes, people have died from asthma, including children and adults. Learn about socioeconomic variables and comorbid factors in ...

Research led by Brock University has found a possible cure for lung diseases typically found in older adults, such as pulmonary fibrosis. The findings are published in the journal Aging Cell.

OSA is categorized by severity, and mild sleep apnea can often be minimized through lifestyle changes. Quitting smoking and ...

The Medical Research Institute (MRI) has confirmed that the Human Metapneumovirus (HMPV), currently spreading in China, is a ...